Search results for: COVID-19 Research
Filter search results
Our Contributions to the Economics of Personalised Medicine
7 March 2018
…frameworks, innovations in pricing and cost effectiveness analyses. Value frameworks This strand of research considers new elements of value for personalised medicine, value frameworks, and how they could…
NICE’s severity modifier: a step in the right direction, but still a long way to go
23 March 2022
…Skedgel, C. 2021. Towards a New Understanding of Unmet Medical Need. Applied Health Economics and Health Policy, 19(6), 785–788. Related Research Zhang, K., Garau, M. (2020) International Cost-Effectiveness Thresholds and…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast…
28 March 2019
…on drug prices, revenues, research and development costs, public sector investments and research and development subsidies, marketing costs and other related information…”. But is price transparency the answer to healthcare…
Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
20 January 2020
…of quality-adjusted life year (QALY) estimation. A new OHE Research Paper, authored by former OHE researcher Koonal Shah and OHE Senior Fellow Nancy Devlin, in collaboration with Juan Manuel Ramos-Goñi and Simone Kreimeier, compares four stated preference methods for…
Does Free Personal Care for the Elderly Reduce Informal Caregiving?
25 February 2013
…costs is a topic for future research. Download Schaffer, Sarah Karlsberg. (2013) The effect of free personal care for the elderly on informal caregiving. Research paper 13/01. London: Office of…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
OHE has just released a research paper that describes an experimental study intended to test whether and how a multi-criteria decision analysis (MCDA) approach can be applied to orphan medicinal…
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…Pharmaceutical Rebates. OHE Research Paper, London: Office of Health Economics. Hampson, G., Towse, A., Dreitlein, B., Henshall, C. and Pearson, S., 2018. Real World Evidence for Coverage Decisions: Opportunities and…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…key to efficient pricing and use of cancer medicines. The Research Paper outlines some for addressing these shortcomings. A new OHE Research Paper by Simon Brassel, Olga Rozanova, and Adrian…
Can the US Afford to Ignore Cost-Effectiveness Evidence in Health Care?
23 July 2013, 11:00pm
At this OHE Lunchtime Seminar, Dr James Chambers of Tufts University presented material drawing on his upcoming OHE Research Paper, which looks at the role cost-effectiveness evidence plays in health…